[1]
N. A. A. Ebrahim, T. S. Eissa, M. A. Hussein, A. Arafat, and N. H. Amin, “Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment”, Asian Pac J Cancer Biol, vol. 10, no. 3, pp. 689–698, Aug. 2025.